<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39-viruses-11-00122">
 <label>39.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tan</surname>
    <given-names>G.S.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>P.S.</given-names>
   </name>
   <name>
    <surname>Hoffman</surname>
    <given-names>R.M.</given-names>
   </name>
   <name>
    <surname>Mazel-Sanchez</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Krammer</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Leon</surname>
    <given-names>P.E.</given-names>
   </name>
   <name>
    <surname>Ward</surname>
    <given-names>A.B.</given-names>
   </name>
   <name>
    <surname>Wilson</surname>
    <given-names>I.A.</given-names>
   </name>
   <name>
    <surname>Palese</surname>
    <given-names>P.</given-names>
   </name>
  </person-group>
  <article-title>Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin</article-title>
  <source>J. Virol.</source>
  <year>2014</year>
  <volume>88</volume>
  <fpage>13580</fpage>
  <lpage>13592</lpage>
  <pub-id pub-id-type="doi">10.1128/JVI.02289-14</pub-id>
  <?supplied-pmid 25210195?>
  <pub-id pub-id-type="pmid">25210195</pub-id>
 </element-citation>
</ref>
